AUD318.06
1.67% today
Australia, Jul 28, 04:10 am CET
ISIN
AU000000COH5
Symbol
COH

Cochlear Stock price

AUD312.83
+18.23 6.19% 1M
-0.09 0.03% 6M
+25.26 8.79% YTD
-17.66 5.34% 1Y
+110.96 54.97% 3Y
+131.85 72.85% 5Y
+233.93 296.47% 10Y
+288.00 1,160.06% 20Y
Australia, Closing price Fri, Jul 25 2025
-1.18 0.38%
ISIN
AU000000COH5
Symbol
COH

Key metrics

Basic
Market capitalization
AUD20.5b
Enterprise Value
AUD20.4b
Net debt
positive
Cash
AUD383.1m
Shares outstanding
65.4m
Valuation (TTM | estimate)
P/E
55.5 | 49.3
P/S
8.9 | 8.4
EV/Sales
8.8 | 8.4
EV/FCF
81.4
P/B
11.0
Dividends
DPS
AUD4.10
Yield 1Y | 5Y
1.3% | 1.3%
Growth 1Y | 5Y
24.2% | 4.4%
Payout 1Y | 3Y
75.5% | 72.3%
Increased
4 Years
Financials (TTM | estimate)
Revenue
AUD2.3b | AUD2.4b
EBITDA
- | AUD638.6m
EBIT
AUD536.3m | AUD552.5m
Net Income
AUD370.5m | AUD415.5m
Free Cash Flow
AUD250.6m
Growth (TTM | estimate)
Revenue
7.4% | 9.0%
EBITDA
- | -
EBIT
9.2% | 3.9%
Net Income
5.7% | 16.4%
Free Cash Flow
-25.1%
Margin (TTM | estimate)
Gross
75.8%
EBITDA
- | 26.2%
EBIT
23.2%
Net
16.1% | 17.1%
Free Cash Flow
10.9%
Financial Health
Equity Ratio
67.1%
Return on Equity
19.4%
ROCE
24.8%
ROIC
20.4%
Debt/Equity
0.1
More
EPS
AUD5.6
FCF per Share
AUD3.8
Short interest
-
Employees
5k
Rev per Employee
AUD440.0k
Show more

Is Cochlear a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Cochlear Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Cochlear forecast:

9x Buy
45%
10x Hold
50%
1x Sell
5%

Analyst Opinions

20 Analysts have issued a Cochlear forecast:

Buy
45%
Hold
50%
Sell
5%

Financial data from Cochlear

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,309 2,309
7% 7%
100%
- Direct Costs 560 560
6% 6%
24%
1,749 1,749
8% 8%
76%
- Selling and Administrative Expenses 936 936
7% 7%
41%
- Research and Development Expense 294 294
9% 9%
13%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 536 536
9% 9%
23%
Net Profit 371 371
6% 6%
16%

In millions AUD.

Don't miss a Thing! We will send you all news about Cochlear directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Head office Australia
CEO Diggory Howitt
Employees 5,047
Founded 1983
Website www.cochlear.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today